These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9076959)
1. The differential regulation and secretion of proteinases from fetal and neonatal fibroblasts by growth factors. Cullen B; Silcock D; Brown LJ; Gosiewska A; Geesin JC Int J Biochem Cell Biol; 1997 Jan; 29(1):241-50. PubMed ID: 9076959 [TBL] [Abstract][Full Text] [Related]
2. Developmental differences in the expression and modulation of extracellular matrix proteases and inhibitors in mouse skin fibroblasts. Island E; Wu H; Warburton D; Anderson K; Tuan TL Wound Repair Regen; 1999; 7(6):467-76. PubMed ID: 10633006 [TBL] [Abstract][Full Text] [Related]
3. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wysocki AB; Kusakabe AO; Chang S; Tuan TL Wound Repair Regen; 1999; 7(3):154-65. PubMed ID: 10417751 [TBL] [Abstract][Full Text] [Related]
4. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444 [TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037 [TBL] [Abstract][Full Text] [Related]
6. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346 [TBL] [Abstract][Full Text] [Related]
7. Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells. Meade-Tollin LC; Way D; Witte MH Acta Histochem; 1999 Jul; 101(3):305-16. PubMed ID: 10443293 [TBL] [Abstract][Full Text] [Related]
8. Differential expression and regulation of extracellular matrix-associated genes in fetal and neonatal fibroblasts. Gosiewska A; Yi CF; Brown LJ; Cullen B; Silcock D; Geesin JC Wound Repair Regen; 2001; 9(3):213-22. PubMed ID: 11472618 [TBL] [Abstract][Full Text] [Related]
9. Proteinases, their inhibitors, and cytokine profiles in acute wound fluid. Baker EA; Leaper DJ Wound Repair Regen; 2000; 8(5):392-8. PubMed ID: 11115151 [TBL] [Abstract][Full Text] [Related]
10. Altered expression of gelatinase and surface-associated plasminogen activator activity by trophoblast cells isolated from placentas of preeclamptic patients. Graham CH; McCrae KR Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):555-62. PubMed ID: 8828413 [TBL] [Abstract][Full Text] [Related]
11. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. Ginestra A; Monea S; Seghezzi G; Dolo V; Nagase H; Mignatti P; Vittorelli ML J Biol Chem; 1997 Jul; 272(27):17216-22. PubMed ID: 9202045 [TBL] [Abstract][Full Text] [Related]
12. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells. Wilson MJ; Sinha AA Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650 [TBL] [Abstract][Full Text] [Related]
13. Effects of platelet-derived growth factor isoforms on plasminogen activation by periodontal ligament and gingival fibroblasts. Agis H; Bauer M; Knebl G; Watzek G; Gruber R J Periodontal Res; 2008 Jun; 43(3):334-42. PubMed ID: 18447857 [TBL] [Abstract][Full Text] [Related]
14. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells. Miyagi E; Yasumitsu H; Hirahara F; Minaguchi H; Koshikawa N; Miyazaki K; Umeda M Jpn J Cancer Res; 1995 Jun; 86(6):568-76. PubMed ID: 7622422 [TBL] [Abstract][Full Text] [Related]
15. Influence of exogenous growth factors on the expression of plasminogen activators and plasminogen activator inhibitors by cells isolated from normal and healing rabbit ligaments. Murphy PG; Hart DA J Orthop Res; 1994 Jul; 12(4):564-75. PubMed ID: 7520487 [TBL] [Abstract][Full Text] [Related]
17. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. Pei XH; Nakanishi Y; Takayama K; Bai F; Hara N Br J Cancer; 1999 Jan; 79(1):40-6. PubMed ID: 10408691 [TBL] [Abstract][Full Text] [Related]
18. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063 [TBL] [Abstract][Full Text] [Related]
19. Proteases as prognostic markers in cancer. Duffy MJ Clin Cancer Res; 1996 Apr; 2(4):613-8. PubMed ID: 9816210 [TBL] [Abstract][Full Text] [Related]
20. Fetal fibroblast contraction of collagen matrices in vitro: the effects of epidermal growth factor and transforming growth factor-beta. Piscatelli SJ; Michaels BM; Gregory P; Jennings RW; Longaker MT; Harrison MR; Siebert JW Ann Plast Surg; 1994 Jul; 33(1):38-45. PubMed ID: 7944195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]